Flow Traders U.S.’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Flow Traders U.S.’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-41,395	Closed	-$1.08M	–	1141
2025 Q4	$1.08M	Buy	41,395 +13,679	+49%	+$352K	0.04%	377
2025 Q3	$655K	Sell	27,716 -17,688	-39%	-$391K	0.03%	529
2025 Q2	$931K	Buy	+45,404	New	+$914K	0.03%	434
2025 Q1	–	Sell	-94,333	Closed	-$2.13M	–	1108
2024 Q4	$2.13M	Buy	+94,333	New	+$2.26M	0.09%	200
2022 Q4	–	Sell	-11,470	Closed	-$303K	–	989
2022 Q3	$303K	Buy	+11,470	New	+$354K	0.02%	627
2022 Q2	–	Sell	-43,315	Closed	-$1.49M	–	911
2022 Q1	$1.49M	Buy	+43,315	New	+$1.53M	0.05%	297
2021 Q4	–	Sell	-19,542	Closed	-$991K	–	912
2021 Q3	$991K	Buy	19,542 +14,068	+257%	+$733K	0.04%	491
2021 Q2	$285K	Sell	5,474 -7,152	-57%	-$336K	0.01%	753
2021 Q1	$577K	Buy	12,626 +6,270	+99%	+$306K	0.03%	465
2020 Q4	$292K	Buy	+6,356	New	+$274K	0.02%	497

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Flow Traders U.S.'s IDNA Position: Q1 2026 in Review

Flow Traders U.S. sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2026, closing a stake of 41,395 shares — an estimated $1.08M sold.

Flow Traders U.S. first reported a position in IDNA in Q4 2020 and held it in 10 quarters. The position peaked at $2.13M in Q4 2024. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

Flow Traders U.S. reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2026 after selling out during the quarter.
Flow Traders U.S. sold 41,395 iShares Genomics Immunology and Healthcare ETF shares in Q1 2026, an estimated $1.08M.
Flow Traders U.S. first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2020 and held it in 10 quarters.
Flow Traders U.S.'s iShares Genomics Immunology and Healthcare ETF position peaked at $2.13M in Q4 2024.
60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on Flow Traders U.S.'s 13F filing for Q1 2026, filed 15 May 2026.